Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys, J Am Coll Cardiol, vol.59, issue.22, pp.1968-76, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00825449
Staphylococcus aureus endocarditis: a consequence of medical progress, JAMA, vol.293, issue.24, pp.3012-3033, 2005. ,
Contemporary clinical profile and outcome of prosthetic valve endocarditis, JAMA, vol.297, issue.12, pp.1354-61, 2007. ,
Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis merged database, Clin Infect Dis, vol.38, issue.9, pp.1323-1330, 2004. ,
An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC), Int J Antimicrob Agents, vol.53, issue.1, pp.9-15, 2019. ,
ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM), Eur Heart J, vol.36, issue.44, pp.3075-128, 2015. ,
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association, Circulation, vol.132, issue.15, pp.1435-86, 2015. ,
Pharmacokinetic interactions with rifampicin : clinical relevance, Clin Pharmacokinet, vol.42, issue.9, pp.819-50, 2003. ,
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, doubleblind, placebo-controlled trial, Lancet, vol.391, pp.668-78, 2018. ,
Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis, vol.30, issue.4, pp.633-641, 2000. ,
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, vol.40, issue.5, pp.373-83, 1987. ,
Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy, Ann Intern Med, vol.98, issue.4, pp.447-55, 1983. ,
Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis, Rev Infect Dis, 1983. ,
Bacteriological outcome of combination versus single-agent treatment for staphylococcal endocarditis, J Antimicrob Chemother, vol.52, issue.5, pp.820-825, 2003. ,
Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study, Ann Thorac Surg, vol.101, issue.6, pp.2243-50, 2016. ,
Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus, Antimicrob Agents Chemother, vol.52, issue.7, pp.2463-2470, 2008. ,
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group, JAMA, vol.279, issue.19, pp.1537-1578, 1998. ,
Penetration of rifampin through Staphylococcus epidermidis biofilms, Antimicrob Agents Chemother, 2002. ,
Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections, Antimicrob Agents Chemother, vol.50, issue.1, pp.55-61, 2006. ,
New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection, J Antimicrob Chemother, vol.71, issue.5, pp.1291-1300, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01274236
Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management, Clin Microbiol Infect, vol.23, issue.6, pp.41-59, 2017. ,
Validated Risk Score for Predicting 6-Month Mortality in Infective Endocarditis, J Am Heart Assoc, vol.5, issue.4, p.3016, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01305479
Comparison of Outcome of Possible Versus Definite Infective Endocarditis Involving Prosthetic or Bioprosthetic Heart Valves, Am J Cardiol, vol.120, issue.10, pp.1884-90, 2017. ,